Pharmaceuticals, Biotechnology and Life Sciences
Biocartis has today strenghten its collaboration with two companies; J&J’s Jansen and Amgen, as it has submitted 510(k) its diagnostics…
Advanced Oncotherapy has successfully tested and calibrated programme at ADAM in Geneva, and that made it possible to integrate the…
Ironwood Pharmaceuticals and Allergan have been testing an irritable bowel syndrome with constipation (IBS-C) drug, a formulation of linaclotide colonic…
Pfizer is moving forward with Ibrance breast cancer drug as the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA).
Janssen Biotech has submitted two Supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval…
Bristol-Myers Squibb Company and Calithera Biosciences, Inc., a clinical stage biotechnology company focused on discovering and developing novel small molecule…
Hansa Medical AB has announced completion of a Phase II study entitled “A Phase II Study to Evaluate the Safety,…
Oasmia Pharmaceutical, a developer of a new generation of drugs within human and veterinary oncology, today presented positive results from…
Kiadis Pharma has announced an update on the second dose Phase II trial with ATIR101 (CR-AIR-008 ).
Galapagos has reported topline results from its Saphira 1 Phase 2 study in cystic fibrosis patients with potentiator GLPG1837.